English
Home > Products > Parecoxib advance intermediate

China Parecoxib advance intermediate Factory

No matter new buyer or aged buyer, We believe in prolonged expression and trustworthy relationship for Parecoxib advance intermediate,CAS NO 509074-26-4,509074-26-4,Parecoxib intermediate,4-(5-Methyl-3-phenyl-4-isoxazolyl), We are devoted to provide professional purification technology and solutions for you!
Parecoxib advance intermediate, Our company regards "reasonable prices, efficient production time and good after-sales service" as our tenet. We hope to cooperate with more customers for mutual development and benefits. We welcome potential buyers to contact us.

Related Products

Hot Products

  • Tetramethylammonium chloride

    Tetramethylammonium chloride

    Product Name:Tetramethylammonium chloride
    Molecular Formula:C4H12ClN
    Molecular Weight:109.6
    CAS Registry Number:75-57-0
  • Triethyl phosphate

    Triethyl phosphate

    Product Name:Triethyl phosphate
    Molecular Formula:C6H15O4P
    Molecular Weight:182.15
    CAS Registry Number:78-40-0
  • 2,6-Difluorobenzaldehyde

    2,6-Difluorobenzaldehyde

    Product Name:2,6-Difluorobenzaldehyde
    Molecular Formula:C7H4F2O
    Molecular Weight:142.1
    CAS Registry Number:437-81-0
  • Tetraacetylribofuranose

    Tetraacetylribofuranose

    Product Name:Tetraacetylribofuranose
    Molecular Formula:C13H18O9
    Molecular Weight:318.28
    CAS Registry Number:13035-61-5
  • Erlotinib

    Erlotinib

    Product Name:Erlotinib
    Molecular Formula:C22H23N3O4
    Molecular Weight;393.44
    CAS Registry Number;183321-74-6
  • 2,3-Dihydro-1H-inden-1-amine hydrochloride

    2,3-Dihydro-1H-inden-1-amine hydrochloride

    Product Name:2,3-Dihydro-1H-inden-1-amine hydrochloride
    Molecular Formula:C9H11N.HCl
    Molecular Weight:170
    CAS Registry Number:32457-23-1/10305-73-4
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept